Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ana Teresa Paquete, Rui Martins, Mark P. Connolly, Marie Meulle, Nítida Pastor, Grégoire Benoist & Patrick Tounian. (2023) Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France. Journal of Market Access & Health Policy 11:1.
Read now
Read now
Mandy Gutknecht, Rabea Reinert & Matthias Augustin. (2019) Review of health economic analyses in atopic dermatitis: how diverse is the literature?. Expert Review of Pharmacoeconomics & Outcomes Research 19:2, pages 127-145.
Read now
Read now
John Su, Susan Prescott, John Sinn, Mimi Tang, Peter Smith, Ralf G. Heine, Jörg Spieldenner & Michael Iskedjian. (2012) Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia. Journal of Medical Economics 15:6, pages 1064-1077.
Read now
Read now
Michael Iskedjian, Ferdinand Haschke, Bechara Farah, Jenny van Odijk, Jade Berbari & Jörg Spieldenner. (2012) Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children. Journal of Medical Economics 15:2, pages 394-408.
Read now
Read now
Michael Iskedjian, Dominique Belli, Bechara Farah, Vincent Navarro & Patrick Detzel. (2012) Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children. Journal of Medical Economics 15:2, pages 378-393.
Read now
Read now
Articles from other publishers (13)
T.H. Sach, E. McManus & N.J. Levell. (2019) Understanding economic evidence for the prevention and treatment of atopic eczema. British Journal of Dermatology 181:4, pages 707-716.
Crossref
Crossref
MF Botteman, AJ Bhanegaonkar, EG Horodniceanu, X Ji, BW Lee, LP Shek, HP Van Bever & P Detzel. (2018) Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore. Singapore Medical Journal 59:8, pages 439-448.
Crossref
Crossref
Emma McManus, Tracey Sach & Nick Levell. (2017) The Use of Decision–Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal. PharmacoEconomics 36:1, pages 51-66.
Crossref
Crossref
Yvan Vandenplas, Pedro Alarcon, David Fleischer, Olle Hernell, Sanja Kolacek, Hugo Laignelet, Bo Lönnerdal, Rita Raman, Jacques Rigo, Silvia Salvatore, Raanan Shamir, Annamaria Staiano, Hania Szajewska, Hans J. Van Goudoever, Andrea von Berg & Way S. Lee. (2016) Should Partial Hydrolysates Be Used as Starter Infant Formula? A Working Group Consensus. Journal of Pediatric Gastroenterology & Nutrition 62:1, pages 22-35.
Crossref
Crossref
Abhijeet Bhanegaonkar, Erica G. Horodniceanu, Xiang Ji, Patrick Detzel, Mark Boguniewicz, Sarah Chamlin, Alan Lake, Laura A. Czerkies, Marc F. Botteman & José M. Saavedra. (2015) Economic Burden of Atopic Dermatitis in High-Risk Infants Receiving Cow's Milk or Partially Hydrolyzed 100% Whey-Based Formula. The Journal of Pediatrics 166:5, pages 1145-1151.e3.
Crossref
Crossref
Abhijeet J BhanegaonkarErica G HorodniceanuAmir Hamzah Abdul LatiffSanjay WoodhullPhaik Choo KhooPatrick DetzelXiang JiMarc F Botteman. (2015) Economic value of atopic dermatitis prevention via infant formula use in high-risk Malaysian infants. Asia Pacific Allergy 5:2, pages 84.
Crossref
Crossref
Marc Botteman & Patrick Detzel. (2015) Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in High-Risk Urban Infants in Southeast Asia. Annals of Nutrition and Metabolism 66:Suppl. 1, pages 26-32.
Crossref
Crossref
Joanne R. Chalmers, Sam F. Bremmer & Eric L. Simpson. 2014. Evidence-Based Dermatology. Evidence-Based Dermatology
127
135
.
Abhijeet J. Bhanegaonkar, Erica G. Horodniceanu, Rizalina Racquel H. Gonzalez, Maria Victoria Canlas Dizon, Patrick Detzel, Esen Erdogan-Ciftci, Bram Verheggen & Marc F. Botteman. (2014) Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in At-Risk Urban Filipino Infants. Value in Health Regional Issues 3, pages 124-135.
Crossref
Crossref
Janina Mertens, Stephanie Stock, Markus Lüngen, Andrea Berg, Ursula Krämer, Birgit Filipiak-Pittroff, Joachim Heinrich, Sibylle Koletzko, Armin Grübl, H.-Erich Wichmann, Carl-P. Bauer, Dietrich Reinhardt, Dietrich Berdel & Andreas Gerber. (2012) Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany. Pediatric Allergy and Immunology 23:6, pages 597-604.
Crossref
Crossref
Mieczysława Czerwionka-Szaflarska & Ewa Łoś-Rycharska. (2012) Profilaktyka alergii pokarmowej już od narodzin. Pediatria Polska 87:4, pages 339-346.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Pediatrics 23:6, pages 700-707.
Crossref
Crossref
Jörg Spieldenner, Dominique Belli, Christophe Dupont, Ferdinand Haschke, Michael Iskedjian, Santiago Nevot Falcó, Hania Szajewska & Andrea von Berg. (2011) Partially Hydrolysed 100% Whey-Based Infant Formula and the Prevention of Atopic Dermatitis: Comparative Pharmacoeconomic Analyses. Annals of Nutrition and Metabolism 59:s1, pages 44-52.
Crossref
Crossref